Presented By- Md Shariq Ansari
B.Pharm, Final year
Roll No- 1455250020
 ANTIMICROBIAL: These are the agents that kills the microorganisms or
inhibits their growth.
Antimicrobial can be grouped according to the
(i) Microorganisms- i.e. Antibiotics against Bacteria, Antifungal against Fungi.
(ii) Function- Microbicidal, Microbiostatics.
ANTIBIOTICS: These are the substance produced by microorganisms,
which selectively suppress the growth or kill the microorganisms at very low
concentration.
SOURCE OF ANTIBIOTICS:
FUNGI BACTERIA ACTINOMYCETES
Penicillin's (penicillium notatum) Polymyxin B Aminoglycosides
Cephalosporin's (cephalosporium) Tyrothricin Chloramphenicol
Griseofulvin (penicillium gresiofuloum) Bacitracin Erythromycin
Cholistin Tetracycline
QUINOLONES
INTRODUCTION:
 Synthetic antimicrobial compounds having quinolone structure (active moiety).
 Bactericidal, broad spectrum antibiotics.
 Primarily active against gram-negative bacteria.
 Most widely used because of their relative safety, their availability in both orally
and parenterally and their favorable pharmacokinetics.
HISTORY:
 The first member Nalidixic Acid was introduced in mid-1960s has usefulness
limited to UTI and G.I.Tract infections because of low potency and high
frequency of bacterial resistance.
 In 1980s by fluorination of the quinolone structure at position no 6 & piperazine
substitution at position 7 resulted in derivatives called fluoroquinolones.
CHEMISTRY:
NALIDIXIC ACID
(1) It is active against gram negative bacteria especially coliforms:-
E.coli
Proteus
Kleibseilla
Enterobacter
Shigella
Psuedomonas ( Except)
(2) It acts by inhibiting bacterial DNA gyrase
PHARMACOKINETICS:
- Orally absorbed, high plasma protein binding and partly metabolized in liver.
- t½ is about 8 hrs.
- Therapeutic concentrations attained in urine & gut lumen are lethal to common
urinary pathogens & diarrhoea causing coliforms.
Bactericidal
antibiotic
ADVERSE EFFECTS:
- G.I. disturbance and rashes mostly occurs.
- Headache, vertigo, visual disturbance are the most common adverse effects.
CONTRAINDICATIONS:
- It is contraindicated in infants.
USES:
- It is primarily used as an Urinary antiseptic.
- Nitrofurantoin should not be given concurrently – Antagonism occurs.
- In the treatment of Diarrhoea caused by coliforms.
Norfloxacin /ciprofloxacin preferred.
FLUOROQUINOLONES
INTRODUCTION:
 These are quinolone antimicrobials having one or more fluorine substitutions.
 Fluorination of quinolone structure at position 6 & piperazine substitution at
position 7 resulted in derivatives called fluoroquinolones.
 High potency.
 Broad spectrum antimicrobial activity.
 Slow development of resistance.
 Better tissue penetration .
 Good tolerability.
 Used for wide variety of infectious diseases
HISTORY:
- The first generation fluoroquinolones was introduced in 1980s, have one fluoro
substitution.
- In 1990s, compounds with additional fluoro group and other substitution have
been developed- further exceeding antimicrobial activity to gram-positive cocci and
anaerobes.
CLASSIFICATION:
First generation Second generation
Levofloxacin
Lomefloxacin
Moxifloxacin
Sparfloxacin
Gemifloxacin
Prulifloxacin
Norfloxacin
Ciprofloxacin
Ofloxacin
Pefloxacin
MECHANISM OFACTION
Quinolones target bacterial DNA gyrase & topoisomerase IV.
 Gram negative bacteria - DNA Gyrase
 Gram positive bacteria - Topoisomerase IV
 Double helical DNA
 Two strands must separate to permit DNA replication / transcription
 “over winding” / excessive positive supercoiling of DNA in front of point of
separation.
 Inhibit protein synthesis.
 DNA Gyrase - introduces negative supercoils into DNA (checks mechanical
hindrance).
 DNA Gyrase has (A & B subunit).
 A subunit - strand cutting function of DNA gyrase.
 A subunit reseals the strand.
Quinolones
- Bind to A - subunit with high affinity & interfere with strand cutting &
resealing function.
- Prevent replication of bacterial DNA during bacterial growth & reproduction.
- finally bacterial cell death occurs .
Antimicrobialagents.pdf
Antimicrobialagents.pdf
Co
ntd
.
Mechanism of resistance-
PHARMACOKINETICS
 Rapid oral absorption.
 High tissue penetrability.
 CSF & aqueous levels are low
 Excreted in urine.
 Urinary & biliary concentrations are 10-50 fold higher than in plasma.
 Excreted in urine.
 Metabolized by liver should not be used in hepatic failure, except Pefloxacin &
moxifloxacin.
Adverse effects
 Hypersenstivity; rashes including photosensitivity.
 Tendonitis & tendon rupture.
 Generally safe
 Nausea, vomiting, abdominal discomfort, bad taste
 CNS:
 headache, dizziness, rarely hallucinations, delirium.
 & seizures have occurred predominantly in patients receiving theophylline or NSAIDs.
 .QTc prolongation.
 Sparfloxacin.
 Gatifloxacin.
 Moxifloxacin.
 Cautious use in patients who are taking drugs that are known to prolong the QT interval .
 tricyclic antidepressants .
 Phenothiazine.
 class I anti-arrhythmics
INTERACTION
- NSAIDs may enhance CNS toxicity of FQ’s
Seizures reported.
Antacids, Sucralfate, Iron salts reduce absorption of FQ,s
THERAPEUTIC USE
1. Urinary tract infection
2. Gonorrhea
3. Typhoid
4. Bone, soft tissues and wound infections.
5. Respiratory infections
6. Tuberculosis
 Ceftriaxone
 Most reliable
 Fastest acting bactericidal drug for enteric fever.
 i.v 4g daily 2 days.
 2g daily till 2 days after fever subsides.
 Bone, joint, soft tissue & wound infections.
 Skin & soft tissue infections.
 joint infections
Antimicrobialagents.pdf

More Related Content

PPSX
Antibiotics course quinolones
PPTX
Quinolones and Fluoroquinolones
PDF
Fluoroquinolones
PDF
Fluoroquinolones
PDF
Quinolones and Fluoroquinolone MOA,ADME,Spectrum of activity of Quinolones.
PDF
ANTIBIOTICS for medical student presentation24.pdf
PPT
Quinolones
PPTX
Fluroquinolones 01 01-19
Antibiotics course quinolones
Quinolones and Fluoroquinolones
Fluoroquinolones
Fluoroquinolones
Quinolones and Fluoroquinolone MOA,ADME,Spectrum of activity of Quinolones.
ANTIBIOTICS for medical student presentation24.pdf
Quinolones
Fluroquinolones 01 01-19

Similar to Antimicrobialagents.pdf (20)

PDF
Quinolones & fluoroquinolones
PPTX
ANTIBIOTICS.pptx presentation medications
PPT
Antibiotics and there classification, classification by various types
PPTX
keys to reducing interactions with quinolones
PPSX
POWERPOINT PRESENTATION ON QUINOLINE
PPTX
Quinolones fluoroquinolones Pharmacology
PPTX
Antibiotics course. 1-Quinolones
PPTX
FLOUROQUINOLONE, MACROLIDE AND MISCELLANOUES PPT.pptx
PPTX
4.5Nkb_Pharmacology_Antibiotics(2)[1](1).pptx
PPTX
ANTIBIOTICS IN DENTISTRY
PPTX
1.4,1.5 tetracyclines and other antibiotics.
PDF
Beta lactame antibiotics.pdf pharmacology
PPTX
Antibiotics.pptx
PPTX
animicrobial drugs.pptx
PPTX
Anti-infective therapy
PPTX
Quinolones, Folic Acid Antagonist and Urinary tract antiseptics
PPTX
Antimicrobail agents-Mr. panneh
PPTX
Quinolones
DOCX
PPTX
Antibiotics
Quinolones & fluoroquinolones
ANTIBIOTICS.pptx presentation medications
Antibiotics and there classification, classification by various types
keys to reducing interactions with quinolones
POWERPOINT PRESENTATION ON QUINOLINE
Quinolones fluoroquinolones Pharmacology
Antibiotics course. 1-Quinolones
FLOUROQUINOLONE, MACROLIDE AND MISCELLANOUES PPT.pptx
4.5Nkb_Pharmacology_Antibiotics(2)[1](1).pptx
ANTIBIOTICS IN DENTISTRY
1.4,1.5 tetracyclines and other antibiotics.
Beta lactame antibiotics.pdf pharmacology
Antibiotics.pptx
animicrobial drugs.pptx
Anti-infective therapy
Quinolones, Folic Acid Antagonist and Urinary tract antiseptics
Antimicrobail agents-Mr. panneh
Quinolones
Antibiotics
Ad

More from Prof. Dr Pharmacology (20)

PPT
4- Biochemistry_2-Glycogen Metabolism.ppt
PPT
Anthelmintics and Antiprotozoal medications.ppt
PDF
PDF
EXPECTORANT.pdf
PPT
ANTIPROTOZOALs.ppt
PDF
EXPECTORANT.pdf
PDF
PPTX
Scabies.pptx
PPT
ANTIPROTOZOAL DRUGS.ppt
PPT
Antimicrobials.ppt
PDF
Skeletal S_Axial Division.pdf
PPT
ANTIPROTOZOAL DRUGS.ppt
PPT
ANTIHELMINTHICs.ppt
PDF
CVS_Lecture 2.pdf
PDF
CNS_Lecture4.pdf
PDF
CNS_Lecture5.pdf
PDF
PDF
PDF
introtopharmacology-101213190521-phpapp02 (1).pdf
4- Biochemistry_2-Glycogen Metabolism.ppt
Anthelmintics and Antiprotozoal medications.ppt
EXPECTORANT.pdf
ANTIPROTOZOALs.ppt
EXPECTORANT.pdf
Scabies.pptx
ANTIPROTOZOAL DRUGS.ppt
Antimicrobials.ppt
Skeletal S_Axial Division.pdf
ANTIPROTOZOAL DRUGS.ppt
ANTIHELMINTHICs.ppt
CVS_Lecture 2.pdf
CNS_Lecture4.pdf
CNS_Lecture5.pdf
introtopharmacology-101213190521-phpapp02 (1).pdf
Ad

Recently uploaded (20)

PPT
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
PDF
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
PDF
FINAL_DRAF_LAYOUT_Handbook_of_Obstetrics_Guideline_PDF.pdf
PDF
HQ_Solutions_Resource_for_the_Healthcare_Quality_Professional_Fourth (1).pdf
PPTX
Nutrition needs in a Surgical Patient.pptx
PDF
Cranial nerve palsies (I-XII) - AMBOSS.pdf
PPTX
SAPIENT3.0 Medi-trivia Quiz (PRELIMS) | F.A.Q. 2025
PPT
BONE-TYPES,CLASSIFICATION,HISTOLOGY,FRACTURE,
PPTX
Bacteriology and purification of water supply
PPTX
Computed Tomography: Hardware and Instrumentation
PDF
Diabetes mellitus - AMBOSS.pdf
PPTX
Gout, Systemic Lupus Erythematous, RA, AS.pptx
PDF
communicable diseases for healthcare - Part 1.pdf
PPTX
Bronchial Asthma2025 GINA Guideline.pptx
PDF
Question paper PYQ.pdf for derma pgs students
PPTX
Phamacology Presentation (Anti cance drugs).pptx
PPTX
Surgical anatomy, physiology and procedures of esophagus.pptx
PDF
FMCG-October-2021........................
PDF
11 Antiepileptic Drugs.pdf file for pharmacy
PPTX
This book is about some common childhood
ANTI-HYPERTENSIVE PHARMACOLOGY Department.ppt
neonatology-for-nurses.pdfggghjjkkkkkkjhhg
FINAL_DRAF_LAYOUT_Handbook_of_Obstetrics_Guideline_PDF.pdf
HQ_Solutions_Resource_for_the_Healthcare_Quality_Professional_Fourth (1).pdf
Nutrition needs in a Surgical Patient.pptx
Cranial nerve palsies (I-XII) - AMBOSS.pdf
SAPIENT3.0 Medi-trivia Quiz (PRELIMS) | F.A.Q. 2025
BONE-TYPES,CLASSIFICATION,HISTOLOGY,FRACTURE,
Bacteriology and purification of water supply
Computed Tomography: Hardware and Instrumentation
Diabetes mellitus - AMBOSS.pdf
Gout, Systemic Lupus Erythematous, RA, AS.pptx
communicable diseases for healthcare - Part 1.pdf
Bronchial Asthma2025 GINA Guideline.pptx
Question paper PYQ.pdf for derma pgs students
Phamacology Presentation (Anti cance drugs).pptx
Surgical anatomy, physiology and procedures of esophagus.pptx
FMCG-October-2021........................
11 Antiepileptic Drugs.pdf file for pharmacy
This book is about some common childhood

Antimicrobialagents.pdf

  • 1. Presented By- Md Shariq Ansari B.Pharm, Final year Roll No- 1455250020
  • 2.  ANTIMICROBIAL: These are the agents that kills the microorganisms or inhibits their growth. Antimicrobial can be grouped according to the (i) Microorganisms- i.e. Antibiotics against Bacteria, Antifungal against Fungi. (ii) Function- Microbicidal, Microbiostatics. ANTIBIOTICS: These are the substance produced by microorganisms, which selectively suppress the growth or kill the microorganisms at very low concentration. SOURCE OF ANTIBIOTICS: FUNGI BACTERIA ACTINOMYCETES Penicillin's (penicillium notatum) Polymyxin B Aminoglycosides Cephalosporin's (cephalosporium) Tyrothricin Chloramphenicol Griseofulvin (penicillium gresiofuloum) Bacitracin Erythromycin Cholistin Tetracycline
  • 3. QUINOLONES INTRODUCTION:  Synthetic antimicrobial compounds having quinolone structure (active moiety).  Bactericidal, broad spectrum antibiotics.  Primarily active against gram-negative bacteria.  Most widely used because of their relative safety, their availability in both orally and parenterally and their favorable pharmacokinetics. HISTORY:  The first member Nalidixic Acid was introduced in mid-1960s has usefulness limited to UTI and G.I.Tract infections because of low potency and high frequency of bacterial resistance.
  • 4.  In 1980s by fluorination of the quinolone structure at position no 6 & piperazine substitution at position 7 resulted in derivatives called fluoroquinolones. CHEMISTRY:
  • 5. NALIDIXIC ACID (1) It is active against gram negative bacteria especially coliforms:- E.coli Proteus Kleibseilla Enterobacter Shigella Psuedomonas ( Except) (2) It acts by inhibiting bacterial DNA gyrase PHARMACOKINETICS: - Orally absorbed, high plasma protein binding and partly metabolized in liver. - t½ is about 8 hrs. - Therapeutic concentrations attained in urine & gut lumen are lethal to common urinary pathogens & diarrhoea causing coliforms. Bactericidal antibiotic
  • 6. ADVERSE EFFECTS: - G.I. disturbance and rashes mostly occurs. - Headache, vertigo, visual disturbance are the most common adverse effects. CONTRAINDICATIONS: - It is contraindicated in infants. USES: - It is primarily used as an Urinary antiseptic. - Nitrofurantoin should not be given concurrently – Antagonism occurs. - In the treatment of Diarrhoea caused by coliforms. Norfloxacin /ciprofloxacin preferred.
  • 7. FLUOROQUINOLONES INTRODUCTION:  These are quinolone antimicrobials having one or more fluorine substitutions.  Fluorination of quinolone structure at position 6 & piperazine substitution at position 7 resulted in derivatives called fluoroquinolones.  High potency.  Broad spectrum antimicrobial activity.  Slow development of resistance.  Better tissue penetration .  Good tolerability.  Used for wide variety of infectious diseases
  • 8. HISTORY: - The first generation fluoroquinolones was introduced in 1980s, have one fluoro substitution. - In 1990s, compounds with additional fluoro group and other substitution have been developed- further exceeding antimicrobial activity to gram-positive cocci and anaerobes. CLASSIFICATION: First generation Second generation Levofloxacin Lomefloxacin Moxifloxacin Sparfloxacin Gemifloxacin Prulifloxacin Norfloxacin Ciprofloxacin Ofloxacin Pefloxacin
  • 9. MECHANISM OFACTION Quinolones target bacterial DNA gyrase & topoisomerase IV.  Gram negative bacteria - DNA Gyrase  Gram positive bacteria - Topoisomerase IV  Double helical DNA  Two strands must separate to permit DNA replication / transcription  “over winding” / excessive positive supercoiling of DNA in front of point of separation.  Inhibit protein synthesis.  DNA Gyrase - introduces negative supercoils into DNA (checks mechanical hindrance).  DNA Gyrase has (A & B subunit).  A subunit - strand cutting function of DNA gyrase.  A subunit reseals the strand.
  • 10. Quinolones - Bind to A - subunit with high affinity & interfere with strand cutting & resealing function. - Prevent replication of bacterial DNA during bacterial growth & reproduction. - finally bacterial cell death occurs .
  • 14. PHARMACOKINETICS  Rapid oral absorption.  High tissue penetrability.  CSF & aqueous levels are low  Excreted in urine.  Urinary & biliary concentrations are 10-50 fold higher than in plasma.  Excreted in urine.  Metabolized by liver should not be used in hepatic failure, except Pefloxacin & moxifloxacin.
  • 15. Adverse effects  Hypersenstivity; rashes including photosensitivity.  Tendonitis & tendon rupture.  Generally safe  Nausea, vomiting, abdominal discomfort, bad taste  CNS:  headache, dizziness, rarely hallucinations, delirium.  & seizures have occurred predominantly in patients receiving theophylline or NSAIDs.  .QTc prolongation.  Sparfloxacin.  Gatifloxacin.  Moxifloxacin.  Cautious use in patients who are taking drugs that are known to prolong the QT interval .  tricyclic antidepressants .  Phenothiazine.  class I anti-arrhythmics
  • 16. INTERACTION - NSAIDs may enhance CNS toxicity of FQ’s Seizures reported. Antacids, Sucralfate, Iron salts reduce absorption of FQ,s THERAPEUTIC USE 1. Urinary tract infection 2. Gonorrhea 3. Typhoid 4. Bone, soft tissues and wound infections. 5. Respiratory infections 6. Tuberculosis
  • 17.  Ceftriaxone  Most reliable  Fastest acting bactericidal drug for enteric fever.  i.v 4g daily 2 days.  2g daily till 2 days after fever subsides.  Bone, joint, soft tissue & wound infections.  Skin & soft tissue infections.  joint infections